Japan, Nov. 4 -- KITE PHARMA INC has got intellectual property rights for 'TACI/BCMA DUAL BINDING MOLECULES.' Other related details are as follows:
Application Number: JP,2025-086025
Category (FI): A61K40/31,A61K39/395@N,C12N15/13,C12N15/12,C12N1/21,C12N1/19,A61K35/17,C12N15/62@Z,C12N15/63@Z,C12N5/0783,C12N5/10,C12P21/08,C12N1/15,C07K19/00,C07K16/46,C07K16/28,C07K14/725,A61P35/00,A61K48/00
Stage: Grant (IP right granted following substantive examination.)
Filing Date: May 23, 2025
Publication Date: Sept. 2, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
